Vita 34 AG
XETRA:V3V
Vita 34 AG
XETRA:V3V
Price:
4.7 EUR
-1.26%
Updated:
May 9, 2024
Vita 34 AG
Gross Profit
|
Vita 34 AG
Gross Profit Peer Comparison
Comparables:
F
FME
F
FRE
E
1846
SYAB
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vita 34 AG
XETRA:V3V
|
Gross Profit
€10.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
4%
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Gross Profit
€4.9B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
|
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Gross Profit
€5.1B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-3%
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Gross Profit
HK$335.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Synlab AG
XETRA:SYAB
|
Gross Profit
€2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Gross Profit?
Gross Profit
10.7m
EUR
10.7m
EUR
Based on the financial report for Sep 30, 2023, Vita 34 AG's Gross Profit amounts to 10.7m EUR.
What is Vita 34 AG's Gross Profit growth rate?
Gross Profit CAGR 10Y
4%
4%
Over the last year, the Gross Profit growth was -45%. The average annual Gross Profit growth rates for Vita 34 AG have been -1% over the past three years , -3% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet
